{
  "ticker": "LDX",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02970904",
  "id": "02970904",
  "pages": 13,
  "price_sensitive": true,
  "date": "20250721",
  "time": "0856",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250721/pdf/06lz8rlprbf5m4.pdf",
  "summary": "### **Material Information Summary (ASX Quarterly Report \u2013 Appendix 4C)**  \n\n#### **Financial & Operational Highlights**  \n- **FY25 Revenue (unaudited):** US$12.4M (+12% YoY).  \n- **Q4 Revenue:** US$2.6M (-26% QoQ), decline due to end of U.S. flu season.  \n- **Product Revenue:** +7% YoY; Services Revenue: -43% YoY.  \n- **FebriDx\u00ae CLIA Waiver Study:** 105/120 target patients enrolled; FDA application expected within **3 months**.  \n- **U.S. Medicare Coverage:** Secured 6 of 7 MACs (85% coverage) at **US$41.38/test**.  \n- **Hologic fFN Project:** Phase 2 complete; additional SOW underway (US$0.6\u20130.8M revenue potential).  \n\n#### **Post-Quarter Developments**  \n- **Exclusive U.S. Distribution Agreement:** Signed with **PHASE Scientific** (US$317M/A$487M total value).  \n  - **Upfront Payments:** US$2M (paid) + US$1.5M on FDA submission + **US$5M** on CLIA waiver approval.  \n- **Loan Facility:** **A$5.0M secured** (15% interest) from major shareholders to support working capital.  \n\n#### **Cash Position**  \n- **Closing Cash (30 June 2025):** **US$2.0M**.  \n- **Q4 Operating Cash Outflow:** **US$1.7M**.  \n- **Funding Runway:** ~3.1 quarters (US$5.2M total available funding).  \n\n#### **Key Upcoming Catalysts**  \n- FDA CLIA waiver submission (est. within 3 months).  \n- PHASE Scientific partnership execution.  \n- BARDA pediatric study initiation (+20% U.S. market potential).  \n\n*Note: No material omissions detected; all figures in USD unless stated.*",
  "usage": {
    "prompt_tokens": 7523,
    "completion_tokens": 431,
    "total_tokens": 7954,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-20T23:12:21.477939"
}